GlobalData, a leading data and analytics company, claims the Covid-19 pandemic presents a difficulty for physicians managing patients with multiple sclerosis (MS), as these sufferers have further reasons for concern.
According to fresh guidelines for treating MS during the pandemic published by national professional bodies and patient organisations, most MS patients will benefit more from continuing their treatments than stopping due to concerns over Covid-19. Read more here.
Go deeper with GlobalData
